Cancer Cell-Sticky Hydrogels to Target the Cell Membrane of Invading Glioblastomas

Area of Science:

• Biomaterials Science
• Cancer Biology
• Neuro-oncology

Background:

• Glioblastoma exhibits aggressive infiltrative growth, leading to indistinct tumor margins and incomplete surgical resection.
• Residual invasive glioblastoma cells resist therapy and cause tumor recurrence, posing a significant clinical challenge.
• Targeting glioblastoma cell invasion is crucial for improving treatment outcomes and preventing recurrence.

Purpose of the Study:

• To design and evaluate a novel cancer cell-sticky hydrogel (CSH) for inhibiting glioblastoma cell invasion.
• To investigate the mechanism of CSH in modifying glioblastoma cell membrane and motility.
• To assess the therapeutic efficacy of CSH, alone and in combination therapy, against glioblastoma in preclinical models.

Main Methods:

• Development of a thiol-enriched hydrogel (CSH) designed to interact with glioblastoma cell membranes.
• In vitro assessment of CSH's effect on glioblastoma cell adhesion and motility.
• Combination therapy studies involving CSH and inhibitors of focal adhesion kinase and hyaluronic acid synthase.
• In vivo evaluation of CSH efficacy in glioblastoma mouse models.

Main Results:

• CSH effectively increased glioblastoma cell adhesion and significantly decreased their invasive motility.
• Cotreatment with CSH and specific inhibitors maximized the anti-invasive effect.
• CSH implantation in mouse models resulted in a significant reduction in tumor mass.
• The CSH demonstrated a mechanism involving modification of the cell membrane with active thiol-enriched interfaces.

Conclusions:

• The developed cancer cell-sticky hydrogel (CSH) presents a novel strategy to inhibit glioblastoma cell invasion.
• CSH enhances cell adhesion and reduces motility, offering a potential therapeutic approach to prevent recurrence.
• Combined therapeutic strategies utilizing CSH show significant potential for glioblastoma treatment.